Work

Crizotinib Treatment in Patients (PTS) with Advanced ROS1-Rearranged Non-Small Cell Lung Cancer (NSCLC)

Year: 2013

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdt459.54

Authors: S.-H. I. Ou, D.-W. Kim, R. Camidge, G.J. Riely, R. Salgia, G. Shapiro, J.W. Clark, L. Tye, A.J. Iafrate, A. Shaw

Institutions: University of California, Irvine, UC Irvine Chao Family Comprehensive Cancer Center, Seoul National University Hospital, University of Colorado Cancer Center, Memorial Sloan Kettering Cancer Center, University of Chicago, Dana-Farber Cancer Institute, Massachusetts General Hospital, Pfizer (United States)

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2153187976

FWCI: 1.216

Cites:

Cited by: 5

Related to: 10